- Filed
- Nov 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q3 2024 · Sep 30, 2024 | $0 |
| Capex | Q3 2024 · Sep 30, 2023 | $34K |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $3.53M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $6.23M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $9.56M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $15.04M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $15.37M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $15.85M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $17.62M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $6.06M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $11.35M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $7.19M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $17.74M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 8.17M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 8.13M sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$42.22M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $4.01M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $13.71M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $46.27M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$1.23 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$5.29 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$1.23 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$5.29 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $2.13M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $7.51M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$10.06M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$42.99M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$10.31M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$40.52M |